Agex Therapeutics Inc Stock

$0.68+0.00 (+0%)
Updated Sep 29, 2023
AGE Price
Fair Value Price
Market Cap
52 Week Low
52 Week High
Dividend Yield
Gross Margin
Operating Margin
Profit Margin
Debt to Equity
Operating Cash Flow
Next Earnings
Nov 13, 2023
Next Dividend

AGE Overview

AgeX Therapeutics, Inc. operates as a biotechnology company. The company is headquartered in Alameda, California and currently employs 12 full-time employees. The firm is focused on the development and commercialization of therapeutics targeting human aging. Its induced Tissue Regeneration (iTR) technology is based telomerase-mediated cellular immortality and regenerative biology. Its pipeline includes two cell-based, two drug-based therapeutic products, online database products and research products. The Company’s AGEX-BAT1 is its cell therapy product candidate that is being developed for the treatment of certain age-related metabolic disorders, such as Type II (adult-onset) diabetes. AGEX-VASC1 is its cell-based therapy that is designed to restore vascular support in aged ischemic tissues such as the aging heart. AGEX-iTR1547 is its drug-based formulation developed to restore regenerative potential in an array of aged tissues afflicted with degenerative disease using its proprietary iTR technology. Renelon is its iTR product candidate designed to promote scar less tissue repair.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AGE scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

AGE is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AGE is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
AGE's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more AGE due diligence checks available for Premium users.

Be the first to know about important AGE news, forecast changes, insider trades & much more!

AGE News


AGE price to earnings (PE)

For valuing profitable companies with steady earnings

AGE price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

AGE's financial health

Profit margin

Net Income
Profit Margin
AGE's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
AGE's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Debt to equity
AGE's short-term liabilities ($24.51M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AGE's long-term liabilities ($10.07M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AGE's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AGE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

AGE's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

AGE vs Biotech Stocks

TickerMarket Cap1d %P/EP/B

Agex Therapeutics Stock FAQ

What is Agex Therapeutics's quote symbol?

(NYSEMKT: AGE) Agex Therapeutics trades on the NYSEMKT under the ticker symbol AGE. Agex Therapeutics stock quotes can also be displayed as NYSEMKT: AGE.

If you're new to stock investing, here's how to buy Agex Therapeutics stock.

What is the 52 week high and low for Agex Therapeutics (NYSEMKT: AGE)?

(NYSEMKT: AGE) Agex Therapeutics's 52-week high was $1.00, and its 52-week low was $0.37. It is currently -32% from its 52-week high and 82.8% from its 52-week low.

How much is Agex Therapeutics stock worth today?

(NYSEMKT: AGE) Agex Therapeutics currently has 37,951,261 outstanding shares. With Agex Therapeutics stock trading at $0.68 per share, the total value of Agex Therapeutics stock (market capitalization) is $25.81M.

Agex Therapeutics stock was originally listed at a price of $2.71 in Nov 29, 2018. If you had invested in Agex Therapeutics stock at $2.71, your return over the last 4 years would have been -74.91%, for an annualized return of -29.22% (not including any dividends or dividend reinvestments).

How much is Agex Therapeutics's stock price per share?

(NYSEMKT: AGE) Agex Therapeutics stock price per share is $0.68 today (as of Sep 29, 2023).

What is Agex Therapeutics's Market Cap?

(NYSEMKT: AGE) Agex Therapeutics's market cap is $25.81M, as of Oct 1, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Agex Therapeutics's market cap is calculated by multiplying AGE's current stock price of $0.68 by AGE's total outstanding shares of 37,951,261.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.